News
All are invited to attend the NCI Technology Transfer Center’s upcoming technology opportunity webinar entitled, “Proteolysis Targeting Chimeras (PROTACs) Targeting PIM Kinase for the Treatment of Cancer,” on April 24, from 11:00 a.m. to 12:00 p.m. The inventor, S enior Investigator, Dr. John
The National Institute of Standards and Technology (NIST) has published a report, written by David P. Leech and John T. Scott, titled Federal Agency Return on Investment in Foreign Patenting. This report details the U.S. federal agencies’ use of foreign patents to protect their intellectual property
Are you interested in licensing or co-developing SARS-CoV-2 targeting antibodies? Investigators at the National Cancer Institute (NCI) have isolated a panel of anti-receptor binding domain (RBD) single domain antibodies (also called ‘nanobodies’) from camel single domain (VHH) phage display
IRP Senior Investigator and Inventor Dr. Peter Choyke has been elected to the National Academy of Medicine (NAM). Dr. Choyke is the Director of the National Cancer Institute’s Molecular Imaging Branch. He was elected for his work on improving diagnosis and treatment through imaging technologies for